Journal
NATURE GENETICS
Volume 41, Issue 7, Pages 833-U96Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ng.390
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research
- International Scholar of the Howard Hughes Medical Institute
- Deutsche Forschungsgemeinschaft [HO 2505/2-1]
- Medical Research Council [G0601943B] Funding Source: researchfish
Ask authors/readers for more resources
Defects in mitochondrial translation are among the most common causes of mitochondrial disease(1), but the mechanisms that regulate mitochondrial translation remain largely unknown. In the yeast Saccharomyces cerevisiae, all mitochondrial mRNAs require specific translational activators, which recognize sequences in 5' UTRs and mediate translation(2). As mammalian mitochondrial mRNAs do not have significant 5' UTRs(3), alternate mechanisms must exist to promote translation. We identified a specific defect in the synthesis of the mitochondrial DNA (mtDNA)-encoded COX I subunit in a pedigree segregating late-onset Leigh syndrome and cytochrome c oxidase (COX) deficiency. We mapped the defect to chromosome 17q by functional complementation and identified a homozygous single-base-pair insertion in CCDC44, encoding a member of a large family of hypothetical proteins containing a conserved DUF28 domain. CCDC44, renamed TACO1 for translational activator of COX I, shares a notable degree of structural similarity with bacterial homologs(4), and our findings suggest that it is one of a family of specific mammalian mitochondrial translational activators.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available